Brokerages Set Integral Ad Science Holding Corp. (NASDAQ:IAS) PT at $13.55

Key Points

• Integral Ad Science Holding Corp. has a consensus "Moderate Buy" rating from twelve brokerages, with six recommending a buy and six a hold on the stock.
• Recent stock performance shows Integral Ad Science's market capitalization at $1.46 billion, with shares trading around $8.81 and a 1-year price target averaging $13.55.
• CEO Lisa Utzschneider sold approximately 9,922 shares of the company's stock at a total value of $80,566.64, indicating a 2.54% decrease in her position ownership.

Shares of Integral Ad Science Holding Corp. (NASDAQ:IAS - Get Free Report) have been assigned an average recommendation of "Moderate Buy" from the twelve ratings firms that are covering the company, Marketbeat reports. Six analysts have rated the stock with a hold recommendation and six have given a buy recommendation to the company. The average 1-year price target among analysts that have issued ratings on the stock in the last year is $13.55.

IAS has been the subject of a number of recent analyst reports. Stifel Nicolaus upped their price target on shares of Integral Ad Science from $13.00 to $14.00 and gave the company a "buy" rating in a report on Tuesday, July 22nd. Wall Street Zen raised shares of Integral Ad Science from a "hold" rating to a "buy" rating in a research report on Sunday, August 10th. Barclays increased their price objective on shares of Integral Ad Science from $9.00 to $10.00 and gave the company an "equal weight" rating in a research report on Friday, August 8th. Finally, Raymond James Financial cut their price objective on shares of Integral Ad Science from $13.00 to $11.00 and set an "outperform" rating on the stock in a research report on Friday, August 8th.

Integral Ad Science Trading Down 3.3%

Shares of IAS traded down $0.29 during mid-day trading on Tuesday, reaching $8.40. The company's stock had a trading volume of 836,254 shares, compared to its average volume of 800,694. The stock has a market cap of $1.40 billion, a PE ratio of 24.71, a P/E/G ratio of 1.20 and a beta of 1.57. Integral Ad Science has a 52 week low of $6.26 and a 52 week high of $13.62. The company's fifty day moving average price is $8.56 and its two-hundred day moving average price is $8.24.

Integral Ad Science (NASDAQ:IAS - Get Free Report) last posted its quarterly earnings results on Thursday, August 7th. The company reported $0.07 EPS for the quarter, beating analysts' consensus estimates of $0.04 by $0.03. Integral Ad Science had a net margin of 9.79% and a return on equity of 5.00%. The company had revenue of $149.20 million during the quarter, compared to analyst estimates of $143.02 million. Integral Ad Science has set its Q3 2025 guidance at EPS. FY 2025 guidance at EPS. Research analysts anticipate that Integral Ad Science will post 0.26 EPS for the current year.

Insider Buying and Selling at Integral Ad Science

In other Integral Ad Science news, CEO Lisa Utzschneider sold 14,904 shares of the firm's stock in a transaction that occurred on Tuesday, July 8th. The shares were sold at an average price of $8.31, for a total transaction of $123,852.24. Following the sale, the chief executive officer owned 379,316 shares in the company, valued at approximately $3,152,115.96. This trade represents a 3.78% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. In the last quarter, insiders have sold 35,073 shares of company stock valued at $289,641. 2.00% of the stock is owned by corporate insiders.

Institutional Investors Weigh In On Integral Ad Science

A number of institutional investors have recently added to or reduced their stakes in the stock. American Century Companies Inc. purchased a new position in shares of Integral Ad Science in the first quarter valued at $711,000. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC grew its holdings in shares of Integral Ad Science by 42.7% in the fourth quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 155,010 shares of the company's stock valued at $1,618,000 after purchasing an additional 46,395 shares in the last quarter. Envestnet Asset Management Inc. lifted its position in Integral Ad Science by 165.6% in the first quarter. Envestnet Asset Management Inc. now owns 84,471 shares of the company's stock worth $681,000 after buying an additional 52,664 shares during the last quarter. Northern Trust Corp lifted its position in Integral Ad Science by 11.0% in the fourth quarter. Northern Trust Corp now owns 677,204 shares of the company's stock worth $7,070,000 after buying an additional 67,038 shares during the last quarter. Finally, Bank of New York Mellon Corp lifted its position in Integral Ad Science by 15.9% in the first quarter. Bank of New York Mellon Corp now owns 291,079 shares of the company's stock worth $2,346,000 after buying an additional 39,988 shares during the last quarter. 95.78% of the stock is owned by hedge funds and other institutional investors.

Integral Ad Science Company Profile

Integral Ad Science Holding Corp. operates as a digital advertising verification company in the United States, the United Kingdom, France, Ireland, Germany, Italy, Singapore, Australia, Japan, India, and the Nordics. The company provides IAS Signal, a cloud-based technology platform that offers return on ad spend needs; and deliver independent measurement and verification of digital advertising across devices, channels, and formats, including desktop, mobile, connected TV, social, display, and video.